RPG Life Sciences
Ticker > Company >

RPG Life Sciences share price

RPG Life Sciences Ltd.

NSE: RPGLIFE BSE: 532983 SECTOR: Pharmaceuticals & Drugs  67.67 K   244   29

2383.00
+8.95 (0.38%)
BSE: 09 Sep 04:01 PM

Price Summary

Today's High

₹ 2434.95

Today's Low

₹ 2362.4

52 Week High

₹ 2976.7

52 Week Low

₹ 1772.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3941.25 Cr.

Enterprise Value

₹ 3801.64 Cr.

No. of Shares

1.65 Cr.

P/E

21.56

P/B

7.08

Face Value

₹ 8

Div. Yield

1.01 %

Book Value (TTM)

₹  336.67

CASH

₹ 139.61 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

72.95 %

EPS (TTM)

₹  110.51

Sales Growth

12.26%

ROE

40.48 %

ROCE

51.79%

Profit Growth

109.03 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of RPG Life Sciences Ltd.

Lomotil Lomofen Naprosyn Azoran Aldactone and Serenace Minmin Tonic Romilast Tricaine Sildura

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year12.26%
3 Year14.08%
5 Year11.71%

Profit Growth

1 Year109.03%
3 Year52.68%
5 Year44.58%

ROE%

1 Year40.48%
3 Year30.06%
5 Year26.47%

ROCE %

1 Year51.79%
3 Year39.89%
5 Year35.68%

Debt/Equity

0

Price to Cash Flow

50.62

Interest Cover Ratio

147.4654

CFO/PAT (5 Yr. Avg.)

0.897772196642017

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 72.95 0.00
Mar 2025 72.95 0.00
Dec 2024 72.95 0.00
Sep 2024 72.81 0.00
Jun 2024 72.81 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 52.6841356800251% for the Past 3 years.
  • Company has been maintaining healthy ROE of 30.0601333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 39.8905% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 147.4654.
  • Company’s PEG ratio is 0.197771278806953.
  • The company has an efficient Cash Conversion Cycle of -53.6664 days.
  • Company has a healthy liquidity position with current ratio of 3.8826.
  • The company has a high promoter holding of 72.95%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.82247964628266.

 Limitations

  • The company has shown a poor revenue growth of 14.0763438559699% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 165.42 172.21 172.71 143.09 168.92
Total Expenditure 126.35 126.28 123.55 117.6 133.45
Operating Profit 39.07 45.93 49.16 25.49 35.47
Other Income 2.37 1.94 3.31 5.06 5.23
Interest 0.15 0.17 0.12 0.18 0.13
Depreciation 5.29 5.31 5.46 5.37 5.14
Exceptional Items 0 -27.3 0 109.9 0
Profit Before Tax 36 15.09 46.89 134.9 35.43
Tax 9.24 10.89 11.96 17.55 9.14
Profit After Tax 26.76 4.2 34.93 117.35 26.29
Adjusted EPS (Rs) 16.18 2.54 21.12 70.96 15.9

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 389.14 440.16 512.81 582.05 653.43
Total Expenditure 318.37 353 409.28 452.91 494.46
Operating Profit 70.77 87.16 103.53 129.14 158.97
Other Income 1.07 3.08 4.8 7.21 14.33
Interest 1.79 1.41 1.15 1.44 1.59
Depreciation 16.47 15.66 15.5 17.07 21.43
Exceptional Items 0 0 0 0 82.6
Profit Before Tax 53.58 73.17 91.68 117.84 232.88
Tax 13.58 21.69 24.04 30.18 49.64
Net Profit 40 51.48 67.64 87.66 183.24
Adjusted EPS (Rs.) 24.19 31.13 40.9 53.01 110.8

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 13.23 13.23 13.23 13.23 13.23
Total Reserves 203.22 242.54 294.37 361.62 517.3
Borrowings 0.74 0.3 0 0 0
Other N/C liabilities 6.45 8.43 8.97 6.48 6.45
Current liabilities 79.69 80.11 102.78 130.96 119.83
Total Liabilities 303.33 344.61 419.35 512.29 656.81
Assets
Net Block 113.3 103.71 124.26 113.53 171.83
Capital WIP 9.44 25.45 15.03 84.78 3.95
Intangible WIP 2.33 5.61 10.41 11.53 12.11
Investments 0 0 0 1.01 1.01
Loans & Advances 2.41 2.93 5.6 3.35 2.66
Other N/C Assets 0 0 0 0 0
Current Assets 175.85 206.91 264.05 298.09 465.25
Total Assets 303.33 344.61 419.35 512.29 656.81
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 53.58 73.17 91.68 117.84 232.88
Adjustment 16.55 13.54 13.31 12.92 -76.22
Changes in Assets & Liabilities -3.53 -3.11 11.06 -7.09 -26.05
Tax Paid -8.33 -18.85 -25.23 -29.31 -52.75
Operating Cash Flow 58.27 64.75 90.82 94.36 77.86
Investing Cash Flow -7.96 -34.66 -105.81 -79.15 -41.8
Financing Cash Flow -10.49 -13.51 -17.12 -20.31 -27.08
Net Cash Flow 39.82 16.58 -32.11 -5.1 8.98

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 72.81 72.81 72.95 72.95 72.95
carniwal investments limi... - - - 0.04 0.04
ektara enterprises llp 15.57 15.57 15.57 15.57 15.57
harsh vardhan goenka 0.16 0.16 0.16 0.16 0.16
mala goenka 0.05 0.05 0.05 0.05 0.05
nucleus life trust (mr. h... 53.80 53.80 53.94 53.94 53.94
stel holdings limited 3.18 3.18 3.18 3.18 3.18
carniwal investments ltd 0.04 0.04 0.04 - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 27.19 27.19 27.05 27.05 27.05
authum investment and inf... 2.02 2.02 2.02 2.02 2.02
investor education and pr... - 1.03 1.10 1.10 1.10
llp 0.08 0.08 0.08 - 0.09
quant mutual fund - quant... - - 1.99 1.98 1.98
mirae asset multicap fund... 1.58 1.58 1.15 1.12 -
investor education and pr... 1.03 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market
Research BOB Capital Market
Research HDFC Securities
Research BOB Capital Market
Research BOB Capital Market

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY24
Presentation Q2FY24
Presentation Q1FY23

Additional Resources & References

Company News

RPG Life Sciences - Quaterly Results 25 Jul, 7:14 PM RPG Life Sciences - Quaterly Results 25 Jul, 7:14 PM RPG Life Sciences - Quaterly Results 28 Apr, 9:24 PM RPG Life Sciences - Quaterly Results 28 Apr, 9:24 PM RPG Life Sciences informs about compliances certificate 11 Apr, 5:58 PM RPG Life Sciences informs about change in management 8 Apr, 3:05 PM RPG Life Sciences informs about newspaper publication 25 Jan, 4:08 PM RPG Life Sciences - Quaterly Results 24 Jan, 7:26 PM RPG Life Sciences - Quaterly Results 24 Jan, 7:26 PM Rpg Life Sciences informs about loss of share certificate 25 Nov, 4:00 PM Rpg Life Sciences informs about investor presentation 8 Nov, 4:42 PM RPG Life Sciences - Quaterly Results 7 Nov, 6:06 PM RPG Life Sciences - Quaterly Results 7 Nov, 6:06 PM Rpg Life Sciences informs about loss of share certificate 26 Oct, 2:51 PM Rpg Life Sciences informs about analyst meet 8 Aug, 2:36 PM Rpg Life Sciences informs about press release 20 Jul, 11:50 AM RPG Life Sciences - Quaterly Results 19 Jul, 5:57 PM RPG Life Sciences - Quaterly Results 19 Jul, 5:57 PM RPG Life Sciences - Quaterly Results 19 Jul, 5:57 PM RPG Life Sciences - Quaterly Results 30 Apr, 7:51 PM RPG Life Sciences - Quaterly Results 30 Apr, 7:51 PM RPG Life Sciences signs Share Subscription, Shareholders' agreement with Sunpound 12 Mar, 5:40 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:49 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:49 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:49 PM RPG Life Sciences informs about details of loss of certificate 20 Dec, 4:36 PM RPG Life Sciences informs about investor presentation 19 Oct, 5:09 PM RPG Life Sciences to execute power delivery agreement with Sunpound 19 Oct, 11:51 AM RPG Life Sciences - Quaterly Results 18 Oct, 6:23 PM RPG Life Sciences - Quaterly Results 18 Oct, 6:23 PM Rpg Life Sciences informs about loss of share certificate 16 Oct, 4:51 PM RPG Life Sciences informs about certificate 11 Oct, 3:53 PM Rpg Life Sciences informs about press release 29 Jul, 2:59 PM RPG Life Sciences - Quaterly Results 28 Jul, 5:50 PM RPG Life Sciences - Quaterly Results 28 Jul, 5:50 PM RPG Life Sciences - Quaterly Results 28 Jul, 5:50 PM RPG Life Sciences informs about transcript of earnings call 8 May, 11:18 AM RPG Life Sciences - Quaterly Results 28 Apr, 6:54 PM RPG Life Sciences - Quaterly Results 28 Apr, 6:54 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:33 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:33 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:33 PM RPG Life Sciences - Quaterly Results 17 Oct, 6:43 PM RPG Life Sciences - Quaterly Results 17 Oct, 6:43 PM RPG Life Sciences - Quaterly Results 17 Oct, 6:43 PM RPG Life Sciences - Quaterly Results 2 Aug, 6:17 PM RPG Life Sciences - Quaterly Results 2 Aug, 6:17 PM RPG Life Sciences - Quaterly Results 29 Apr, 6:21 PM RPG Life Sciences informs about newspaper publications 27 Jan, 4:52 PM RPG Life Sciences informs about loss of share certificate 24 Nov, 4:33 PM

RPG Life Sciences Stock Price Analysis and Quick Research Report. Is RPG Life Sciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse RPG Life Sciences. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). RPG Life Sciences has a PE ratio of 21.6816097237857 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. RPG Life Sciences has ROA of 31.3472% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. RPG Life Sciences has a Current ratio of 3.8826.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. RPG Life Sciences has a ROE of 40.478%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. RPG Life Sciences has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: RPG Life Sciences has reported revenue growth of 12.2636% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of RPG Life Sciences for the current financial year is 24.3285432257472%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for RPG Life Sciences is Rs 24 and the yield is 1.0071%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of RPG Life Sciences is Rs 110.5084. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of RPG Life Sciences in Ticker for free. Also, one can get the intrinsic value of RPG Life Sciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

RPG Life Sciences FAQs

Q1. What is RPG Life Sciences share price today?
Ans: The current share price of RPG Life Sciences is Rs 2396.

Q2. What is the market capitalisation of RPG Life Sciences?
Ans: RPG Life Sciences has a market capitalisation of Rs 3962.747994 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of RPG Life Sciences?
Ans: The PE ratio of RPG Life Sciences is 21.6816097237857 and the P/B ratio of RPG Life Sciences is 7.116733740001, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of RPG Life Sciences share?
Ans: The 52-week high share price of RPG Life Sciences is Rs 2974.95, and the 52-week low share price of RPG Life Sciences is Rs 1835.

Q5. Does RPG Life Sciences pay dividends?
Ans: Currently, RPG Life Sciences pays dividends. Dividend yield of RPG Life Sciences is around 1.0071%.

Q6. What are the face value and book value of RPG Life Sciences shares?
Ans: The face value of RPG Life Sciences shares is Rs 8, while the book value per share of RPG Life Sciences is around Rs 336.6713. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of RPG Life Sciences?
Ans: RPG Life Sciences has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of RPG Life Sciences?
Ans: The ROE of RPG Life Sciences is 40.478% and ROCE of RPG Life Sciences is 51.7948%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is RPG Life Sciences a good buy for the long term?
Ans: The RPG Life Sciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is RPG Life Sciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the RPG Life Sciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check RPG Life Sciences’s financials?
Ans: You can review RPG Life Sciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about RPG Life Sciences

RPG Life Sciences Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

RPG Life Sciences Ltd. is a leading pharmaceutical company specializing in the manufacturing and marketing of quality pharmaceutical products. With a rich history spanning several decades, RPG Life Sciences has become a trusted name in the healthcare industry. The company is committed to delivering innovative and affordable medicines to improve the quality of life for patients across the globe.

RPG Life Sciences Ltd. Share Price

Stay up-to-date with RPG Life Sciences Ltd.'s share price and track its performance in the stock market. Our website provides real-time and historical share price data, enabling investors to make informed decisions. Our pre-built screening tools allow you to analyze RPG Life Sciences Ltd.'s share price, helping you identify trends and patterns.

RPG Life Sciences Ltd. Balance Sheet

The balance sheet is an essential financial statement that provides a snapshot of RPG Life Sciences Ltd.'s financial position at a given point in time. By examining the company's assets, liabilities, and equity, investors can assess its financial stability and solvency. Our website offers access to RPG Life Sciences Ltd.'s balance sheet as a downloadable document. Take advantage of our premium features, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, to perform a thorough evaluation of the balance sheet.

RPG Life Sciences Ltd. Annual Report

The annual report is a comprehensive document that provides insights into RPG Life Sciences Ltd.'s performance, strategies, and future prospects. It includes information on the company's financials, business operations, milestones, and achievements. At our website, you can easily download RPG Life Sciences Ltd.'s annual report, enabling you to dive deeper into the company's performance and outlook.

RPG Life Sciences Ltd. Dividend

RPG Life Sciences Ltd. is committed to creating value for its shareholders. One way the company rewards its shareholders is through dividends. Dividends provide investors with a portion of the company's profits. Stay updated on RPG Life Sciences Ltd.'s dividend history and declared dividends on our website. Analyze the company's dividend payment pattern and evaluate its potential as an income-generating investment.

RPG Life Sciences Ltd. Quarterly Result

Track RPG Life Sciences Ltd.'s quarterly performance and stay informed about the company's financial results. Our website offers access to RPG Life Sciences Ltd.'s quarterly reports as downloadable documents. Combine the quarterly results with our premium features, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, to gain a comprehensive understanding of the company's financials and performance trends.

RPG Life Sciences Ltd. Stock Price

Stay connected to the latest stock price movements of RPG Life Sciences Ltd. Our website provides real-time updates on the stock's performance, helping you make informed investment decisions. Utilize RPG Life Sciences Ltd.'s stock price chart to identify price trends and patterns. Our pre-built screening tools offer additional insights into RPG Life Sciences Ltd.'s stock price, empowering you to conduct a thorough analysis.

RPG Life Sciences Ltd. News

Keep yourself updated with the latest news and developments related to RPG Life Sciences Ltd. Our website provides a dedicated news section, aggregating news articles and press releases relevant to the company. Stay informed about market trends, regulatory changes, product launches, partnerships, and more. Access to reliable and relevant news can help you make informed investment decisions.

RPG Life Sciences Ltd. Concall Transcripts

Eager to gain insights directly from RPG Life Sciences Ltd.'s management team? Our website offers downloadable concall transcripts, allowing you to access firsthand information shared during the company's conference calls. By reviewing the concall transcripts, investors can gain a deeper understanding of RPG Life Sciences Ltd.'s strategies, performance updates, and future prospects.

RPG Life Sciences Ltd. Investor Presentations

Our website provides downloadable investor presentations by RPG Life Sciences Ltd. These presentations offer valuable insights into the company's business model, growth strategies, financial performance, and objectives. The presentations are an excellent resource for investors looking to understand RPG Life Sciences Ltd.'s value proposition and investment potential.

RPG Life Sciences Ltd. Promoters

The promoters of RPG Life Sciences Ltd. play a crucial role in the company's success. Our website provides detailed information about the promoters and their contributions to the company's growth. Understanding the promoters' background, experience, and vision can provide investors with valuable insights and help them evaluate the company's long-term prospects.

RPG Life Sciences Ltd. Shareholders

Explore RPG Life Sciences Ltd.'s shareholder base and understand the company's ownership structure. Our website offers insights into the major shareholders of RPG Life Sciences Ltd., providing information about institutional investors, mutual funds, and individual investors holding significant positions in the company. Understanding the shareholder base can help investors assess the confidence and support the company enjoys from the market.

By providing comprehensive stock analysis resources like company profiles, share prices, balance sheets, annual reports, dividends, quarterly results, stock prices, price charts, news, concall transcripts, investor presentations, promoters, and shareholders, our website strives to empower long-term stock investors looking for in-depth analysis. Additionally, our premium features, such as fair value calculation tools like DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, offer advanced insights to support your investment decisions. Access these resources and tools on our website to gain a comprehensive understanding of RPG Life Sciences Ltd.'s stock and make informed investment choices. 

RPG Life Sciences Balance Sheet Overview

RPG Life Sciences Share Capital Stability

RPG Life Sciences has maintained a consistent share capital at Rs 13.23 Cr. from March 2020 to March 2024, indicating stability in the company’s equity financing structure.

RPG Life Sciences Reserves Growth

The company has shown robust growth in its reserves, increasing from Rs 163.34 Cr. in March 2020 to Rs 361.62 Cr. by March 2024. This significant increase suggests strong internal fund accumulation, potentially enhancing the company's financial robustness.

RPG Life Sciences Debt Reduction

RPG Life Sciences has effectively managed its borrowings, reducing them from Rs 1.52 Cr. in March 2020 to zero by March 2023. This represents a move towards a less leveraged balance sheet, reducing financial risk and dependency on external financing.

RPG Life Sciences Asset Expansion

The total assets of RPG Life Sciences have risen from Rs 267.91 Cr. in March 2020 to Rs 512.29 Cr. in March 2024, showing substantial growth. Notably, the investment in Capital Work-In-Progress (WIP) has seen a sharp rise to Rs 84.78 Cr. in March 2024, up from Rs 7.28 Cr. in March 2020, reflecting ongoing expansions or upgrades.

This data is an analysis for the standalone balance sheet of the company.

Investors can also explore related sectors or peer companies for a comprehensive market analysis or consider upcoming IPOs for diversified investment opportunities.

Read More
X